GlassScriptPhysician profile
Ravi Gupta
NPI 1437600624
$1,020.09
in general payments reported to CMS, 2019-2025
12 companies · $187 in 2025
The $187 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $114 · 2022: $307 · 2023: $266 · 2024: $146 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $599.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $215.13 | 2022-2024 | Jardiance |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.06 | 2021-2022 | |
| Glaxosmithkline, LLC. | $177.79 | 2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals LP | $85.73 | 2021 | |
| Novartis Pharmaceuticals Corporation | $78.42 | 2025 | |
| Pfizer INC. | $64.04 | 2024-2025 | |
| Daiichi Sankyo INC. | $50.37 | 2024 | Enhertu |
| Gilead Sciences, INC. | $49.05 | 2025 | Trodelvy |
| Exact Sciences Corporation | $32.40 | 2024-2025 | Cologuard Collection Kit |
| Insulet Corporation | $29.18 | 2021-2023 | Omnipod |
| Janssen Biotech, INC. | $23.92 | 2024 | Erleada, Akeega |
| Astellas Pharma US INC | $15.00 | 2023 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.